Erratum: SWIFT: Prospective 48-week study to evaluate efficacy and safety of switching to emtricitabine/tenofovir from lamivudine/abacavir in virologically suppressed HIV-1 infected patients on a boosted protease inhibitor containing antiretroviral regimen (Clinical Infectious Diseases (2013) 56:11 (1637-45))

R. Campo, E. DeJesus, U. F. Bredeek, K. Henry, H. Khanlou, K. Logue

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)779
Number of pages1
JournalClinical Infectious Diseases
Issue number5
StatePublished - Sep 1 2013

Cite this